Immunovative, Inc. Appoints Dr. David L. Wolitzky as Independent Member of Company’s Board of Directors Effective Immediately

New York, New York (PRWEB) March 19, 2013

Immunovative, Inc. (OTCQB: IMUN) (“IMUN” or “the Company”) has today announced the appointment of Dr. David L. Wolitzky (“Dr. Wolitzky”) as an independent member of Company’s Board of Directors (“Board”). This appointment shall be effective immediately, and Dr. Wolitzky currently joins the Company’s CEO, Seth M. Shaw (“Mr. Shaw”), as the second member of the Board. As an independent director, Dr. Wolitzky will assist in the Company in establishing corporate governance protocols and guidelines, as the Company takes meaningful steps to become compliant with Sarbanes-Oxley regulations. The Company’s short term goal is to appoint a minimum of 5 highly qualified members to its Board, with at least 2 members categorized as Independent Directors.


Leave a Comment

You must be logged in to post a comment.



The Psychology of Selling